FAAS
EGRX

First Allied Advisory Services’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

First Allied Advisory Services’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6,430
Closed -$517K – 1160
2015
Q2 		$517K Buy
+6,430
New +$517K 0.02% 611
2014
Q2 		– Sell
-10,600
Closed -$134K – 1077
2014
Q1 		$134K Buy
+10,600
New +$134K 0.01% 934